Who are HotSpot Therapeutics's investors?

HotSpot Therapeutics's investors include Atlas Venture, B Capital Group, B4 Capital, MRL Ventures Fund, Sofinnova Partners, Solasta Ventures, SR One Capital Management.

How much funding has HotSpot Therapeutics raised?

HotSpot Therapeutics has disclosed $100M raised across 1 round.

HotSpot Therapeutics

Founded 2017 · 57 employees on LinkedIn · 7 known investors

HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies. The company serves patients requiring advanced therapeutic interventions.

AI & Machine Learning Biotech Healthtech

Founders & leadership

Board

Bruce BoothChairman

Investors · 7

Atlas VentureCambridge · $500K – $1M

B Capital GroupManhattan Beach · $10M – $50M

B4 Capital$10M – $50M

MRL Ventures FundCambridge · $25M

Sofinnova PartnersParis · $540K – $27M

Solasta VenturesBoston

SR One Capital ManagementRedwood City

Funding

SEC filings, press & company announcements

$100M disclosed across 1 round · 2021

$100MSeries CNov 2021 · 2 sources
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through HotSpot Therapeutics went on to found or lead other companies.

Samantha TruexMember of the Board; Chair of Audit CommitteeFounded Upstream Bio +1 Rachel HumphreyScientific Advisory Board MemberFounded Normunity

Competitors · 1

by search overlap

Fiveable8 shared keywordsFiveable provides AI-powered exam preparation for AP classes, offering practice questions with automated scoring and personalized study tools for high school students.

Companies competing with HotSpot Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic - HotSpot Therapeuticshotspotthera.com · Nov 2021

HotSpot Therapeutics Raises $100M in Series C Fundingfinsmes.com · Nov 2021

HotSpot Therapeutics Raises $65 Million - Global Genesglobalgenes.org · May 2020

HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicinesprnewswire.com · May 2020

Frequently asked questions

What does HotSpot Therapeutics do?: HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies. The company serves patients requiring advanced therapeutic interventions.
Who are HotSpot Therapeutics's investors?: HotSpot Therapeutics's investors include Atlas Venture, B Capital Group, B4 Capital, MRL Ventures Fund, Sofinnova Partners, Solasta Ventures, SR One Capital Management.
How much funding has HotSpot Therapeutics raised?: HotSpot Therapeutics has disclosed $100M raised across 1 round.